ERP29 and breast carcinoma: Additionally, ERp29 was found to regulate breast cancer cell growth arrest through p38 activation and upregulation of the ER stress protein p58IPK14, and cancer cell survival against genotoxic stress induced by doxorubicin15,16, cisplatin (CDDP)17, gemcitabine18, and radiation19,20.